Amanta Healthcare Ltd

Thu 27/08/2026,15:16:1 | NSE : AMANTA

₹187.21-3.82 (-2.00%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 187.21

Previous Close

₹ 191.03

Volume

7318

Mkt Cap ( ₹ Cr)

₹ 726.92

High

₹ 187.21

Low

₹ 187.21

52 Week High

₹ 205.57

52 Week Low

₹ 92.00

Book Value Per Share

₹ 57.56

Dividend Yield

0.00

Face Value

₹ 10.00

What's Your Call?

Collective community sentiment on Amanta Healthcare Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Amanta Healthcare Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Amanta Healthcare - General Updates

    25 Aug 2026, 4:53PM Amanta Healthcare Limited has informed the Exchange regarding 'Intimation - Regulation 36(1)(b) of the SEBI Listing Regulations'.
  • Amanta Healthcare - Intimation - Regulation 36(1)(B) Of The SEBI Listing Regulations

    25 Aug 2026, 4:50PM Intimation - Regulation 36(1)(b) of the SEBI Listing Regulations
  • Amanta Healthcare - Copy of Newspaper Publication

    25 Aug 2026, 12:27PM Amanta Healthcare Limited has informed the Exchange about Copy of Newspaper Publication for dispatch of Annual Report of the 31st Annual General Meeti
  • Amanta Healthcare - Shareholders meeting

    24 Aug 2026, 12:36PM Amanta Healthcare Limited has informed the Exchange about Notice of Annual General Meeting to be held on 16th September, 2026
  • Amanta Healthcare - Annual Report For Financial Year 2025-26

    24 Aug 2026, 12:29PM Annual Report for Financial Year 2025-26
  • Amanta Healthcare - Notice Of 31St Annual General Meeting And Annual Report For F.Y. 2025-26

    24 Aug 2026, 12:11PM Notice of 31st Annual General Meeting and Annual Report for F.Y. 2025-26
  • Amanta Healthcare - Reg. 34 (1) Annual Report.

    24 Aug 2026, 11:56AM Annual Report for Financial Year 2025-26
  • Amanta Healthcare Q1 net profit down 5.70% at Rs 3.31 cr

    19 Aug 2026, 8:20PM The company reported standalone net profit of Rs 3.31 crore for the quarter ended June 30, 2026 as compared to Rs 3.51 crore in the same period last y
  • Amanta Healthcare - Copy of Newspaper Publication

    12 Aug 2026, 4:28PM Amanta Healthcare Limited has informed the Exchange about Copy of Newspaper Publication - Advertisement addressed to Shareholders for Annual General M
  • Amanta Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    8 Aug 2026, 4:50PM Amanta Healthcare Limited has informed the Exchange about Transcript
  • Amanta Healthcare - Monitoring Agency Report

    8 Aug 2026, 12:07PM Monitoring Agency Report for the quarter ended June 30, 2026
  • Amanta Healthcare - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    8 Aug 2026, 4:47PM Earnings Call Transcript for quarter ended June 30, 2026
  • Amanta Healthcare - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    8 Aug 2026, 12:04PM Monitoring Agency Report for the quarter ended June 30, 2026
  • Amanta Healthcare - Copy of Newspaper Publication

    7 Aug 2026, 2:38PM Amanta Healthcare Limited has informed the Exchange about Copy of Newspaper Publication
  • Amanta Healthcare - General Updates

    7 Aug 2026, 2:36PM Amanta Healthcare Limited has informed the Exchange about Newspaper Publication of Financial Results for Quarter ended June 30, 2026
  • Amanta Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    6 Aug 2026, 2:50PM Amanta Healthcare Limited has informed the Exchange about Link of Recording
  • Amanta Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    6 Aug 2026, 2:47PM Submission of Audio Recording of Post Results Conference Call held on August 6, 2026
  • Amanta Healthcare - Press Release

    5 Aug 2026, 6:59PM Amanta Healthcare Limited has informed the Exchange regarding a press release dated August 05, 2026, titled ""Amanta Healthcare Limited announcesQ1FY2
  • Amanta Healthcare - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    5 Aug 2026, 6:55PM Announcement under Reg 30- Press Release
  • Amanta Healthcare - Statement Of Deviation Or Variation In Utilization Of Funds, If Any, Under Regulation 32 Of The Securitie

    5 Aug 2026, 6:49PM Statement of Deviation or Variation in utilization of funds, if any
  • Amanta Healthcare - Announcement under Regulation 30 (LODR)-Investor Presentation

    5 Aug 2026, 6:47PM Investor Presentation
  • Amanta Healthcare - Investor Presentation

    5 Aug 2026, 6:43PM Amanta Healthcare Limited has informed the Exchange about Investor Presentation
  • Amanta Healthcare - General Updates

    5 Aug 2026, 6:42PM Amanta Healthcare Limited has informed the Exchange about statement of deviation, if any
  • Amanta Healthcare - Outcome of Board Meeting

    5 Aug 2026, 6:39PM Amanta Healthcare Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
  • Amanta Healthcare - To Approve Unaudited Financial Results For The Quarter Ended 30Th June 2026

    5 Aug 2026, 6:32PM To approve unaudited Financial Results for the Quarter ended 30th June 2026
  • Amanta Healthcare - Board Meeting Outcome for To Approval Unaudited Financial Results For Quarter Ended 30Th June 2026

    5 Aug 2026, 6:25PM To approve unaudited Financial Results for quarter ended 30th June 2026
  • Amanta Healthcare - Change in Management

    5 Aug 2026, 5:51PM Amanta Healthcare Limited has informed the Exchange about change in Senior Management Personnel of the Company
  • Amanta Healthcare - Announcement under Regulation 30 (LODR)-Change in Management

    5 Aug 2026, 5:47PM Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 for change in Senior Management Personnel of the Company
  • Amanta Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    3 Aug 2026, 11:59AM Amanta Healthcare Limited has informed the Exchange about Schedule of meet
  • Amanta Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    3 Aug 2026, 11:54AM Intimation of Schedule of the Earnings Conference Call for Q1 ended June 30, 2026
  • Amanta Healthcare - Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results For The Quarter E

    29 Jul 2026, 5:00PM Amanta Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider an
  • Amanta Healthcare has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    18 Jul 2026, 7:20PM As of June 2026, 63.80% is owned by Promoters and 36.20% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 26.86% and Forei
  • Amanta Healthcare - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    10 Jul 2026, 4:25PM Amanta Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Amanta Healthcare - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    10 Jul 2026, 4:22PM Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
  • Amanta Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    9 Jul 2026, 6:13PM Amanta Healthcare Limited has informed the Exchange about Schedule of meet and outcome
  • Amanta Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    9 Jul 2026, 6:11PM Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
  • Amanta Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    6 Jul 2026, 5:10PM Amanta Healthcare Limited has informed the Exchange about Schedule of meet
  • Amanta Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    6 Jul 2026, 5:07PM Intimation of Schedule of Investor Meet
  • Amanta Healthcare - Updates

    1 Jul 2026, 12:24PM Amanta Healthcare Limited has informed the Exchange regarding 'Submission of Disclosures under Regulation 7(2) of the SEBI (Prohibition of InsiderTrad
  • Amanta Healthcare - General Updates

    29 Jun 2026, 4:50PM Amanta Healthcare Limited has informed the Exchange about copy of Newspaper Publication
  • Amanta Healthcare - Trading Window

    27 Jun 2026, 1:54PM Amanta Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations
  • Amanta Healthcare - Updates

    22 Jun 2026, 1:47PM Amanta Healthcare Limited has informed the Exchange regarding 'Intimation under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulatio
  • Amanta Healthcare - Intimation Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015

    22 Jun 2026, 1:44PM Intimation under Regulation 7(2) of the SEBI(Prohibition of Insider Trading) Regulations, 2015
  • Amanta Healthcare - Updates

    18 Jun 2026, 2:04PM Amanta Healthcare Limited has informed the Exchange regarding 'Intimation under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulatio
  • Amanta Healthcare - Intimation Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015

    18 Jun 2026, 2:01PM Intimation under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015
  • Amanta Healthcare - Updates

    17 Jun 2026, 2:29PM Amanta Healthcare Limited has informed the Exchange regarding 'Intimation under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulatio
  • Amanta Healthcare - Submission Of Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations,

    17 Jun 2026, 2:24PM Submission of Disclosure under Regulation 7(2) of the SEBI ( Prohibition of Insider Trading) Regulations, 2015 (the \Insider Trading Regulations\)
  • Amanta Healthcare - General Updates

    30 May 2026, 7:36PM Amanta Healthcare Limited has informed the Exchange about General Updates
  • Amanta Healthcare - Intimation For Commissioning Of Solar Power Plant For Captive\r\nConsumption

    30 May 2026, 7:30PM Intimation for commissioning of solar power plant for captive consumption
  • Amanta Healthcare - Statement Of Deviation Or Variation In Utilization Of Funds, If Any

    29 May 2026, 3:04PM statement of deviation or variation in utilization of funds, if any
  • Amanta Healthcare - Statement Of Deviation Or Variation In Utilization Of Funds, If Any.

    29 May 2026, 3:01PM statement of deviation or variation of funds, if any

Key fundamentals

Evaluate the intrinsic value of Amanta Healthcare Ltd stock 

Name March-26 March-25 March-24
Assets 454.6291 291.3844 271.5179
Liabilities 454.6291 291.3844 271.5179
Equity 38.8294 28.8294 26.8294
Gross Profit 59.8585 59.6685 57.49
Net Profit 14.8752 10.5007 3.6332
Cash From Operating Activities 48.4464 46.62 58.073
NPM(%) 5.17 3.82 1.29
Revenue 287.6767 274.7082 280.3403
Expenses 227.8182 215.0397 222.8503
ROE(%) 6.65 4.69 1.62

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Amanta Healthcare Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 890.25 2.36 22.52 109.01 -26.19 0.56
Lotus Eye Hospital and Institute Ltd 112.63 0.91 1609.00 397.21 0.39 0.00
Vaishali Pharma Ltd 8.33 1.96 26.03 2491.83 15.42 0.00
Astec Lifesciences Ltd 585.90 -1.28 0.00 425.59 -363.14 0.00

Company Info

Our Company was originally incorporated on December 21, 1994 as Marck Parenterals (India) Limited with RoC, Gujarat, at Ahmedabad by converting the existing Partnership firm "Marck Parenterals (India)" under Part IX of the Companies Act, 1956 and received the Certificate for Commencement of Business on January 06, 1995. The name of our Company was changed to "Marck Biosciences Limited" pursuant to a special resolution passed by our shareholders on October 29, 2005, and a fresh certificate of incorporation issued by the Registrar of Companies, Gujarat, at Ahmedabad, dated November 2, 2005. Subsequently, the name of our Company was changed to "Amanta Healthcare Limited" pursuant to a special resolution passed by our shareholders on June 12, 2014, and a fresh certificate of incorporation dated June 24, 2014 issued by the Registrar of Companies, Gujarat, at Ahmedabad.Major Events and Milestones:1994- Converted in a Public Limited Company1997- Started implementation of Large Volume Parenterals (LVP) project for Formulations, Fluid Therapy & Irrigation Solution1998- Commencement of L-1 in Block A2002- Launched a specialised production line "LVP Line II" for the manufacture of Large Volume Parenterals in Kheda, Gujarat2005- Launched a specialised production line "SVP Line I" for the manufacture of Small Volume Parenterals in Kheda, Gujarat.2007- Added L-III Large Volume Parenterals Facility for 500 ml products in Block -A2008- Launched a specialised production line "SVP line II" for the manufacture of Small Volume Parenterals in Kheda, Gujarat.- Approval from The National Pharmaceutical Control Bureau - Malaysia (a PIC member)2021- Launched a specialised production line "SteriPort -Debottlenecking"2023- Received WHO- GMP certification for Manufacturing facility at Kheda, Gujarat2024- Got CE Mark Certification for Eye Wash Solutions- Manufacturing out of seven (7) active production lines including SVP and LVP- Granted permission to manufacture and market the product named Linezolid I.V. injection (Domestic)

Our Company was originally incorporated on December 21, 1994 as Marck Parenterals (India) Limited with RoC, Gujarat, at Ahmedabad by converting the existing Partnership firm "Marck Parenterals (India)" under Part IX of the Companies Act, 1956 and received the Certificate for Commencement of Business on January 06, 1995. The name of our Company was changed to "Marck Biosciences Limited" pursuant to a special resolution passed by our shareholders on October 29, 2005, and a fresh certificate of incorporation issued by the Registrar of Companies, Gujarat, at Ahmedabad, dated November 2, 2005. Subsequently, the name of our Company was changed to "Amanta Healthcare Limited" pursuant to a special resolution passed by our shareholders on June 12, 2014, and a fresh certificate of incorporation dated June 24, 2014 issued by the Registrar of Companies, Gujarat, at Ahmedabad.Major Events and Milestones:1994- Converted in a Public Limited Company1997- Started implementation of Large Volume Parenterals (LVP) project for Formulations, Fluid Therapy & Irrigation Solution1998- Commencement of L-1 in Block A2002- Launched a specialised production line "LVP Line II" for the manufacture of Large Volume Parenterals in Kheda, Gujarat2005- Launched a specialised production line "SVP Line I" for the manufacture of Small Volume Parenterals in Kheda, Gujarat.2007- Added L-III Large Volume Parenterals Facility for 500 ml products in Block -A2008- Launched a specialised production line "SVP line II" for the manufacture of Small Volume Parenterals in Kheda, Gujarat.- Approval from The National Pharmaceutical Control Bureau - Malaysia (a PIC member)2021- Launched a specialised production line "SteriPort -Debottlenecking"2023- Received WHO- GMP certification for Manufacturing facility at Kheda, Gujarat2024- Got CE Mark Certification for Eye Wash Solutions- Manufacturing out of seven (7) active production lines including SVP and LVP- Granted permission to manufacture and market the product named Linezolid I.V. injection (Domestic)

Parent Organisation

Amanta Healthcare Ltd.

Founded

21/12/1994

Managing Director

Mr.Bhavesh Patel

NSE Symbol

AMANTABE

FAQ